Merck & Co., Inc. is 47.8x more valuable than Centessa Pharmaceuticals plc by market capitalization ($294.03 B vs $6.15 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CNTA | MRK |
|---|---|---|
| Market cap | $6.15 B | $294.03 B |
| US-listed rank | #1264 | #45 |
| Revenue (latest FY) | $15.00M | $65.01B |
| Net income (latest FY) | -$197.53M | $18.25B |
| Net margin | -1316.9% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 579 | 996 |
Merck & Co., Inc. is 47.8x more valuable than Centessa Pharmaceuticals plc by market capitalization ($294.03 B vs $6.15 B).
In their latest fiscal years, Centessa Pharmaceuticals plc reported $15.00M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Centessa Pharmaceuticals plc and Merck & Co., Inc., or browse the full rankings.